Workbook for Rau's Respiratory Care Pharmacology - Elsevier EBook on VitalSource, 11th Edition
Elsevier eBook on VitalSource
Now $39.59
Take an easier path to respiratory pharmacology mastery. Workbook for Rau's Respiratory Care Pharmacology, 11th Edition features a variety of engaging learning exercises for each of the 22 chapters in the core text. Examples include NBRC®-type questions, critical-thinking exercises, case studies, definitions, and additional content review to further your understanding of challenging pharmacology principles, develop your critical-thinking skills, and prepare you for success on the board exam. Thoroughly revised and updated, the Rau’s workbook is part of the complete learning package for your continued success!
-
- NEW! Updated content reflects changes to drug approval, aerosol medication devices and associated issues related to COVID-19, FDA-approved medications, and asthma and COPD treatment protocols
-
- Answers reference back to the objectives in the core text to help you easily review your areas of weakness
- Case studies and critical-thinking questions promote the application of clinical skills
- Key illustrations from the text provide a visual review to enhance your study of important concepts
- Engaging pharmacology exercises reinforce foundational content, such as key terms and definitions
-
Unit I: Basic Concepts and Principles in Pharmacology
1. Introduction to Respiratory Care Pharmacology
2. Principles of Drug Action
3. Administration of Aerosolized Agents
4. Calculating Drug Doses
5. The Central and Peripheral Nervous Systems
Unit II: Drugs Used to Treat the Respiratory System
6. Adrenergic (Sympathomimetic) Bronchodilators
7. Anticholinergic (Parasympatholytic) Bronchodilators
8. Xanthines
9. Mucus-Controlling Drug Therapy
10. Surfactant Agents
11. Corticosteroids in Respiratory Care
12. Nonsteroidal Antiasthma Agents
13. Aerosolized Antiinfective Agents
14. Antimicrobial Agents
15. Cold and Cough Agents
16. Selected Agents of Pulmonary Value
17. Neonatal and Pediatric Aerosolized Drug Therapy
Unit III: Critical Care, Cardiovascular, and Polysomnography Agents
18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
19. Diuretic Agents
20. Drugs Affecting the Central Nervous System
21. Vasopressors, Inotropes, and Antiarrhythmic Agents
22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
23 Sleep and Sleep Pharmacology -
-
Ways of Reading
- The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
- This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
- All content can be read as read aloud speech or dynamic braille
- Has alternative text descriptions for images
-
Conformance
- The publication contains a conformance statement that it meets the EPUB Accessibility 1.1, WCAG 2.1, Level AA standard. Please see https://bornaccessible.benetech.org/certified-publishers/ for further details of our compatibility testing.
- The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
- For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
- For queries regarding accessibility information, contact [email protected]
- The publication was certified on 12-02-2026
-
Navigation
- Table of contents to all chapters of the text via links
- Elements such as headings, tables, etc. for structured navigation
- Page list to go to pages from the print source version
-
Rich Content
- Information-rich images are described by extended descriptions
-
Hazards
- The publication contains no hazards
-
Product Content
- Content includes any type of illustrations.
- The primary content is text.
- Content includes a significant number of actionable (clickable) web links to external content, downloadable resources, supplementary material, etc.
- Content includes figures, diagrams, charts and/or graphs, including other 'mechanical' (i.e. non-photographic) illustrations.
- Content includes a significant number of web links (printed URLs, QR codes etc.).
- Content includes text within images, including text-as-text embedded in diagrams, charts, or within images containing speech balloons, thought bubbles, captions, etc.
-
Legal Considerations
- No information is available
-
Additional Accessibility Information
- Content is enhanced with ARIA roles to optimize organization and facilitate navigation
- Page breaks included from the original print source
- For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
- The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
- Ultra-high contrast between text and background
- E-publication includes basic navigation (usually less detailed than TOC-based navigation)
- Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
- All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
- Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
- The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
-
Ways of Reading
